Turning Point Therapeutics
-$3.76 (-7.43%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TPTX and other ETFs, options, and stocks.
About TPTX
Turning Point Therapeutics, Inc. is a clinical-stage oncology biopharmaceutical company, which engages in designing and developing next-generation therapies that target genetic drivers of cancer to improve the lives of patients. Its product pipeline include Repotrectinib, TPX-0022, TPX-0046, and TPS-O131, a next-gen ALK inhibitor.
CEO
Athena Countouriotis
Employees
142
Headquarters
San Diego, California
Founded
2013
TPTX Key Statistics
Market Cap
2.31B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
949.15K
High Today
$51.25
Low Today
$46.66
Open Price
$50.90
Volume
510.50K
52 Week High
$141.30
52 Week Low
$42.51
Analyst Ratings
91%
of 11 ratings
Buy
90.9%
Hold
9.1%
Sell
0%
TPTX Earnings
-$1.21
-$0.81
-$0.40
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 9, After Hours